SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-11-12

Thu, Nov 12, 2026 - Page 27

13819 indexed SquawkNews stories from this UTC day. Showing 3121-3240.

EQUITY 5982EARNINGS 4842FX 653NEWS 460CENTRAL_BANK 417MACRO 293GEOPOLITICS 273REGULATION 219MNA 175RATES 149ENERGY 148COMMODITIES 145
M Applied Materials expects Q1 adjusted EPS of $4.15-$4.55 EARNINGS | Nov 12, 2026, 09:03 PM UTC H NY Fed: The Federal Reserve did not intervene in FX markets during Q3; US Treasury purchased Japanese Yen in FX markets during the same period. NY Fed: The Federal Reserve did not intervene in FX markets during Q3; US Treasury purchased Japanese Yen in FX markets during the same period. CENTRAL_BANK | Nov 12, 2026, 09:03 PM UTC L Erasca Q3 2026 net loss widens 68% to $51.33 million Erasca Q3 2026 net loss widens 68% to $51.33 million Erasca's third-quarter 2026 net loss widene EQUITY | Nov 12, 2026, 09:03 PM UTC L Citigroup files Form FWP EQUITY | Nov 12, 2026, 09:03 PM UTC M HawkEye 360 Raises 2026 Revenue Guidance to $225M-$227M Third-quarter revenue was $59.3 million, up 84% from $32.2 million a year earlier. Backlog was $300.3 million as of September 30, 2026. The company also raised 2026 non-GAAP Adjusted EBITDA guidance to $38 million-$40 mi EARNINGS | Nov 12, 2026, 09:03 PM UTC L POSaBIT Q3 net loss narrows 80% year over year to USD 118,328 POSaBIT Q3 net loss narrows 80% year over year to USD 118,328 POSaBIT Systems’ third-quarter 202 FX | Nov 12, 2026, 09:03 PM UTC L Financial Stocks Decline Late Thursday Afternoon Financial stocks declined late Thursday afternoon. EQUITY | Nov 12, 2026, 09:03 PM UTC L Assembly Biosciences Reports Third Quarter 2026 Financial Results and Recent Updates Initiated Phase 2 clinical study of ABI-6250 in patients with chronic hepatitis delta virus infection —— Exercised 40% U.S. Profit-Share option for the HSV helicase primase inhibitor program —— Received first $75 million EARNINGS | Nov 12, 2026, 09:03 PM UTC L InspireMD Reports Third Quarter 2026 Financial Results Received FDA approval of CGuard® Prime for Transcarotid Arterial Revascularization (TCAR) procedur REGULATION | Nov 12, 2026, 09:03 PM UTC L Liftoff Mobile Announces Third Quarter 2026 Financial Results REDWOOD CITY, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Liftoff Mobile, Inc. EQUITY | Nov 12, 2026, 09:03 PM UTC M AMAT Guides Q1 2027 Adjusted EPS to $4.35 ± $0.20 EARNINGS | Nov 12, 2026, 09:03 PM UTC L INSPIREMD Q3 NET INCOME USD -9.762 MILLION INSPIREMD Q3 NET INCOME USD -9.762 MILLION FX | Nov 12, 2026, 09:03 PM UTC L INSPIREMD Q3 REVENUE USD 2.242 MILLION INSPIREMD Q3 REVENUE USD 2.242 MILLION EARNINGS | Nov 12, 2026, 09:03 PM UTC L INSPIREMD Q3 INCOME FROM OPERATIONS USD -9.953 MILLION INSPIREMD Q3 INCOME FROM OPERATIONS USD -9.953 MILLION FX | Nov 12, 2026, 09:03 PM UTC L BRIEF-Mannatech Q3 Sales USD 24.872 Million Nov 12 (Reuters) - Mannatech Q3 gross profit USD 18.58 million. EARNINGS | Nov 12, 2026, 09:03 PM UTC L LIFTOFF MOBILE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS LIFTOFF MOBILE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 09:03 PM UTC L InspireMD 3Q Rev $2.24M >NSPR InspireMD 3Q Rev $2.24M >NSPR EQUITY | Nov 12, 2026, 09:03 PM UTC L InspireMD 3Q Loss/Shr 12c >NSPR InspireMD 3Q Loss/Shr 12c >NSPR EQUITY | Nov 12, 2026, 09:03 PM UTC L BRIEF-Mannatech Q3 Sales USD 24.872 Million BRIEF-Mannatech Q3 Sales USD 24.872 Million Nov 12 (Reuters) - Mannatech Q3 gross profit USD 18.58 m EARNINGS | Nov 12, 2026, 09:03 PM UTC L InspireMD 3Q Loss $9.76M >NSPR InspireMD 3Q Loss $9.76M >NSPR EQUITY | Nov 12, 2026, 09:03 PM UTC L INSPIREMD REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS INSPIREMD REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 09:03 PM UTC L MDxHealth 3Q Loss $12.3M >MDXH MDxHealth 3Q Loss $12.3M >MDXH EQUITY | Nov 12, 2026, 09:03 PM UTC L INSPIREMD Q3 GROSS PROFIT USD 240 THOUSAND INSPIREMD Q3 GROSS PROFIT USD 240 THOUSAND EARNINGS | Nov 12, 2026, 09:03 PM UTC L MDxHealth 3Q Rev $22.7M >MDXH MDxHealth 3Q Rev $22.7M >MDXH EQUITY | Nov 12, 2026, 09:03 PM UTC L INSPIREMD Q3 BASIC EPS USD -0.12 INSPIREMD Q3 BASIC EPS USD -0.12 EARNINGS | Nov 12, 2026, 09:03 PM UTC L InspireMD Reports Third Quarter 2026 Financial Results InspireMD Reports Third Quarter 2026 Financial Results - Received FDA approval of CGuard® Prime for REGULATION | Nov 12, 2026, 09:03 PM UTC L Liftoff Mobile Announces Third Quarter 2026 Financial Results Liftoff Mobile Announces Third Quarter 2026 Financial Results REDWOOD CITY, Calif., Nov. 12, 2026 (G EQUITY | Nov 12, 2026, 09:03 PM UTC L MDxHealth 3Q Loss/Shr 16c >MDXH MDxHealth 3Q Loss/Shr 16c >MDXH EQUITY | Nov 12, 2026, 09:03 PM UTC L Lifeway Foods Q3 net income drops 93% to $260,000; Q3 net sales rise 19% to $67.8 million Lifeway Foods Q3 net income drops 93% to $260,000; Q3 net sales rise 19% to $67.8 million Lifewa EQUITY | Nov 12, 2026, 09:03 PM UTC L FRMO FY27 First-Quarter Net Loss Widens Year Over Year to $35.75 Million FRMO FY27 First-Quarter Net Loss Widens Year Over Year to $35.75 Million FRMO's FY27 first-quart EQUITY | Nov 12, 2026, 09:02 PM UTC L Applied shares trade near flat after quarterly report EQUITY | Nov 12, 2026, 09:02 PM UTC L CV Sciences Q3 2026 net loss narrows 76% year over year to $93,000 CV Sciences Q3 2026 net loss narrows 76% year over year to $93,000 CV Sciences’ third-quarter 20 EQUITY | Nov 12, 2026, 09:02 PM UTC M AMAT Q4 Adjusted EPS $4.16 vs. IBES Estimate $4.05 EARNINGS | Nov 12, 2026, 09:02 PM UTC L BRIEF-Prime Medicine, Inc. Q3 EPS USD -0.22 Nov 12 (Reuters) - Prime Medicine, Inc. Q3 income from operations USD -39.926 million. EARNINGS | Nov 12, 2026, 09:02 PM UTC L Birchcliff Energy Swings to Q3 2026 Net Income of $10.4 Million Birchcliff Energy Swings to Q3 2026 Net Income of $10.4 Million Birchcliff Energy swung to Q3 20 EQUITY | Nov 12, 2026, 09:02 PM UTC H *-- Earnings Flash (HTFL) Heartflow, Inc. Reports Q3 Revenue $72.9M, vs. FactSet Est of $65.2M *-- Earnings Flash (HTFL) Heartflow, Inc. Reports Q3 Revenue $72.9M, vs. EARNINGS | Nov 12, 2026, 09:02 PM UTC L Ascend Wellness Q3 2026 Net Loss More Than Doubles Quarter-on-Quarter to USD 27.95 Million Ascend Wellness Q3 2026 Net Loss More Than Doubles Quarter-on-Quarter to USD 27.95 Million Ascen FX | Nov 12, 2026, 09:02 PM UTC L WISE GROUP PLC H1 PRETAX PROFIT GBP 334.9 MILLION WISE GROUP PLC H1 PRETAX PROFIT GBP 334.9 MILLION EARNINGS | Nov 12, 2026, 09:02 PM UTC L Kodiak Sciences Q3 Net Loss Widens 8% to $66.22 Million Kodiak Sciences Q3 Net Loss Widens 8% to $66.22 Million Kodiak Sciences’ third-quarter 2026 net EQUITY | Nov 12, 2026, 09:02 PM UTC L BRIEF-MacroGenics Q3 Net Income USD -20.1 Million Nov 12 (Reuters) - MacroGenics Q3 revenue USD 18.7 million vs. IBES estimate USD 46.4 million. EARNINGS | Nov 12, 2026, 09:02 PM UTC L MDxHealth SA (MDXH) Reports Flat Q3 Revenue and Wider Operating Loss Q3 revenue was flat year over year at $22.7M; operating loss rose 86% to $8.1M and net loss rose 26% to $12.3M. Adjusted EBITDA loss widened to $6.3M from $0.9M.Material DetailsContext by AI AnalystThis is a quarterly re EARNINGS | Nov 12, 2026, 09:02 PM UTC L BRIEF-Lifeway Foods Q3 Income From Operations USD 1.085 Million Nov 12 (Reuters) - Lifeway Foods Q3 gross profit USD 12.164 million. EARNINGS | Nov 12, 2026, 09:02 PM UTC L WISE GROUP PLC: EXPECTS FY27 INCOME BEFORE TAX MARGIN AROUND TOP OF OUR 20-25% RANGE WISE GROUP PLC: EXPECTS FY27 INCOME BEFORE TAX MARGIN AROUND TOP OF OUR 20-25% RANGE EQUITY | Nov 12, 2026, 09:02 PM UTC M Birchcliff Raises Q4 2026 Production Guidance to 90,000 boe/d Birchcliff also set 2026 production guidance at 84,000 boe/d, expects $105 million in free funds flow and declared a $0.03-per-share quarterly dividend. EARNINGS | Nov 12, 2026, 09:02 PM UTC L Celesc Board Approves Fundraising Strategy and Public Call EQUITY | Nov 12, 2026, 09:02 PM UTC L MANNATECH Q3 SALES USD 24.872 MILLION MANNATECH Q3 SALES USD 24.872 MILLION FX | Nov 12, 2026, 09:02 PM UTC L MANNATECH Q3 NET INCOME USD 8.905 MILLION MANNATECH Q3 NET INCOME USD 8.905 MILLION FX | Nov 12, 2026, 09:02 PM UTC L MANNATECH Q3 PRETAX PROFIT USD -1.954 MILLION MANNATECH Q3 PRETAX PROFIT USD -1.954 MILLION EARNINGS | Nov 12, 2026, 09:02 PM UTC L BRIEF-Smith Micro Software Q3 Net Income USD -1.698 Million BRIEF-Smith Micro Software Q3 Net Income USD -1.698 Million Nov 12 (Reuters) - Smith Micro Software FX | Nov 12, 2026, 09:02 PM UTC L MANNATECH Q3 GROSS PROFIT USD 18.58 MILLION MANNATECH Q3 GROSS PROFIT USD 18.58 MILLION EARNINGS | Nov 12, 2026, 09:02 PM UTC L BRIEF-MacroGenics Q3 Net Income USD -20.1 Million BRIEF-MacroGenics Q3 Net Income USD -20.1 Million Nov 12 (Reuters) - MacroGenics Q3 revenue USD 18.7 EARNINGS | Nov 12, 2026, 09:02 PM UTC L BRIEF-Prime Medicine, Inc. Q3 EPS USD -0.22 BRIEF-Prime Medicine, Inc. Q3 EPS USD -0.22 Nov 12 (Reuters) - Prime Medicine, Inc. EARNINGS | Nov 12, 2026, 09:02 PM UTC L MANNATECH REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2026 MANNATECH REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2026 EQUITY | Nov 12, 2026, 09:02 PM UTC L BRIEF-Lifeway Foods Q3 Income From Operations USD 1.085 Million BRIEF-Lifeway Foods Q3 Income From Operations USD 1.085 Million Nov 12 (Reuters) - Lifeway Foods Q3 FX | Nov 12, 2026, 09:02 PM UTC L Mannatech Reports Financial Results for Third Quarter 2026 FLOWER MOUND, Texas, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Man EQUITY | Nov 12, 2026, 09:02 PM UTC M Assembly Biosciences Receives $75 Million Gilead Fee Assembly Biosciences received its first $75 million collaboration extension fee from Gilead and projects its cash runway into 2029. It also initiated a Phase 2 study of ABI-6250 and elected a 40% U.S. cost and profit sha EQUITY | Nov 12, 2026, 09:02 PM UTC L MANNATECH Q3 INCOME FROM OPERATIONS USD 272 THOUSAND MANNATECH Q3 INCOME FROM OPERATIONS USD 272 THOUSAND FX | Nov 12, 2026, 09:02 PM UTC L BRIEF-HeartBeam Q3 Basic EPS USD -0.05 BRIEF-HeartBeam Q3 Basic EPS USD -0.05 Nov 12 (Reuters) - HeartBeam Q3 income from operations USD -3 EARNINGS | Nov 12, 2026, 09:02 PM UTC L Mannatech Reports Financial Results for Third Quarter 2026 Mannatech Reports Financial Results for Third Quarter 2026 FLOWER MOUND, Texas, Nov. 12, 2026 (GLOBE EQUITY | Nov 12, 2026, 09:02 PM UTC L BRIEF-HeartBeam Q3 Basic EPS USD -0.05 Nov 12 (Reuters) - HeartBeam Q3 income from operations USD -3.457 million. EARNINGS | Nov 12, 2026, 09:02 PM UTC L BRIEF-Smith Micro Software Q3 Net Income USD -1.698 Million Nov 12 (Reuters) - Smith Micro Software Q3 operating expenses USD 5.558 million. FX | Nov 12, 2026, 09:02 PM UTC L Mannatech 3Q Sales $24.9M >MTEX Mannatech 3Q Sales $24.9M >MTEX EQUITY | Nov 12, 2026, 09:02 PM UTC L WISE GROUP PLC: EXPECTS FY27 NET REVENUE GROWTH IN UPPER HALF OF 15-20% MEDIUM-TERM TARGET RANGE AT 17.5-20% WISE GROUP PLC: EXPECTS FY27 NET REVENUE GROWTH IN UPPER HALF OF 15-20% MEDIUM-TERM TARGET RANGE AT EARNINGS | Nov 12, 2026, 09:02 PM UTC L Rocket Pharmaceuticals Q3 2026 Net Loss Narrows to $49.2 Million Rocket Pharmaceuticals Q3 2026 Net Loss Narrows to $49.2 Million Rocket Pharmaceuticals’ third-q EQUITY | Nov 12, 2026, 09:02 PM UTC H *-- Earnings Flash (PBIT.CN) POSaBIT Systems Corporation Reports Q3 Revenue $2.3M *-- Earnings Flash (PBIT.CN) POSaBIT Systems Corporation Reports Q3 Revenue $2.3M EARNINGS | Nov 12, 2026, 09:02 PM UTC L Mannatech 3Q EPS $4.61 >MTEX Mannatech 3Q EPS $4.61 >MTEX EARNINGS | Nov 12, 2026, 09:02 PM UTC L WISE GROUP PLC: EXPECTS FY27 NET REVENUE GROWTH TO BE IN UPPER HALF OF 15-20% MEDIUM-TERM TARGET RANGE ON A CONSTANT CURRENCY BASIS WISE GROUP PLC: EXPECTS FY27 NET REVENUE GROWTH TO BE IN UPPER HALF OF 15-20% MEDIUM-TERM TARGET RAN EARNINGS | Nov 12, 2026, 09:02 PM UTC L Microsoft Is Preparing Automated Systems to Restart Unresponsive Servers Microsoft is preparing systems to detect and restart unresponsive servers. EQUITY | Nov 12, 2026, 09:02 PM UTC H Birchcliff Energy Ltd. Announces Strong Q3 2026 Results and Preliminary 2027 Guidance Birchcliff Increases Q4 2026 Production GuidanceCALGARY, Alberta, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Birchcliff Energy Ltd. (“Birchcliff” or the “Corporation”) TSX:BIR is pleased to announce its Q3 2026 financial and oper EARNINGS | Nov 12, 2026, 09:02 PM UTC H HawkEye 360 Announces Third Quarter 2026 Financial Results Revenue of $59.3 million, up 84% compared to the prior-year period of $32.2 millionAchieved record international revenue of 23.3 million, up 76% compared to the prior-year periodBacklog of $300.3 million as of September EARNINGS | Nov 12, 2026, 09:02 PM UTC L MDxHealth Q3 Operating Loss Widens 86% to USD 8.13 Million MDxHealth Q3 Operating Loss Widens 86% to USD 8.13 Million MDxHealth’s third-quarter 2026 net lo FX | Nov 12, 2026, 09:02 PM UTC M Assembly Biosciences Q3 Net Loss More Than Doubles to $20.26 Million EQUITY | Nov 12, 2026, 09:01 PM UTC L Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights Ipsoprubart Advancing in Global Registrational Program as Potential First Treatment for sHLH Broadly EQUITY | Nov 12, 2026, 09:01 PM UTC L IZEA Reports Q3 2026 Revenue of $6.2 million, 94% increase in Managed Services Bookings ORLANDO, Fla., Nov. 12, 2026 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. EARNINGS | Nov 12, 2026, 09:01 PM UTC L Lifeway Foods, Inc. (LWAY) Reports Q3 Sales of $67.8M, 28th Straight Growth Quarter Lifeway Foods reported Q3 2026 net sales of $67.8M, its 28th consecutive quarter of year-over-year net sales growth. It expects elevated cost pressure in Q4 and gross margin expansion and improved profitability in 2027.M EQUITY | Nov 12, 2026, 09:01 PM UTC L Microsoft Prepares Automated Systems to Restart Unresponsive Servers EQUITY | Nov 12, 2026, 09:01 PM UTC L Curis, Inc. (CRIS) Reports Q3 Net Loss of $8.1M; Cash Runway Into Q1 2027 Curis reported a Q3 2026 net loss of $8.1M, versus $7.7M in Q3 2025, and no revenue, versus $3.2M. It had $5.0M cash at September 30 and said October placement proceeds should fund operations into Q1 2027.Material Detail EARNINGS | Nov 12, 2026, 09:01 PM UTC L Prime Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates - First patient dosed in global Phase 1/2 clinical trial of PM577a in Wilson disease, the first cli EQUITY | Nov 12, 2026, 09:01 PM UTC L Micron Announces Participation in Investor Events Micron said it will participate in investor events. EQUITY | Nov 12, 2026, 09:01 PM UTC L XTI Aerospace Restructures About $4.7 Million in Promissory Notes XTI Aerospace also secured a waiver and amendment to its revolving credit facility with JPMorgan Chase Bank, N.A. EQUITY | Nov 12, 2026, 09:01 PM UTC L Talphera Reports Third Quarter 2026 Financial Results and Provides Business Update Briefing document submitted to FDA for a Sprint Meeting requesting a close of the NEPHRO CRRT study enrollment based on number of patients enrolled as of December 31, 2026Pivotal NEPHRO study currently exceeds 80% power REGULATION | Nov 12, 2026, 09:01 PM UTC L BlossomHill Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights Alignment with the US Food and Drug Administration (FDA) on 50 mg twice daily as the recommended Pha REGULATION | Nov 12, 2026, 09:01 PM UTC M AMAT Q4 Sales Reach USD 10,409 Million AMAT reported Q4 sales of USD 10,409 million, versus an IBES estimate of USD 10,299 million. EARNINGS | Nov 12, 2026, 09:01 PM UTC L NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update Development Programme for NUC-7738 Advances with Three Presentations Planned at ESMO Immuno-Oncology EQUITY | Nov 12, 2026, 09:01 PM UTC L AMAT Reports Q4 EPS of USD 3.4 EARNINGS | Nov 12, 2026, 09:01 PM UTC L JOURNEY MEDICAL CORPORATION Q3 EPS USD -0.05 JOURNEY MEDICAL CORPORATION Q3 EPS USD -0.05 EARNINGS | Nov 12, 2026, 09:01 PM UTC L MACROGENICS Q3 NET INCOME USD -20.1 MILLION MACROGENICS Q3 NET INCOME USD -20.1 MILLION FX | Nov 12, 2026, 09:01 PM UTC L Talphera Reports Third Quarter 2026 Financial Results and Provides Business Update Briefing document submitted to FDA for a Sprint Meeting requesting a close of the NEPHRO CRRT study REGULATION | Nov 12, 2026, 09:01 PM UTC L JOURNEY MEDICAL CORPORATION Q3 REVENUE USD 19 MILLION VS. IBES ESTIMATE USD 20.3 MILLION JOURNEY MEDICAL CORPORATION Q3 REVENUE USD 19 MILLION VS. IBES ESTIMATE USD 20.3 MILLION EARNINGS | Nov 12, 2026, 09:01 PM UTC M AMAT Q4 Adjusted Net Income $3.321 Billion vs. $3.242 Billion Estimate AMAT reported Q4 adjusted net income of USD 3,321 million, compared with the IBES estimate of USD 3,242 million. EARNINGS | Nov 12, 2026, 09:01 PM UTC L Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highli EQUITY | Nov 12, 2026, 09:01 PM UTC L AMAT Q4 Adjusted Gross Margin 50.6% EARNINGS | Nov 12, 2026, 09:01 PM UTC L WISE GROUP PLC H1 REVENUE GBP 1,453.1 MILLION WISE GROUP PLC H1 REVENUE GBP 1,453.1 MILLION EARNINGS | Nov 12, 2026, 09:01 PM UTC L Rocket Pharma Expects Cash, Cash Equivalents and Investments as of Sept 30 to Fund Ops Into 3Q 2028 >RCKT Rocket Pharma Expects Cash, Cash Equivalents and Investments as of Sept 30 to Fund Ops Into 3Q 2028 >RCKT EQUITY | Nov 12, 2026, 09:01 PM UTC L LIFEWAY FOODS Q3 NET INCOME USD 260 THOUSAND LIFEWAY FOODS Q3 NET INCOME USD 260 THOUSAND FX | Nov 12, 2026, 09:01 PM UTC L AMAT Reports Q4 Adjusted Free Cash Flow of $2,616 Million EARNINGS | Nov 12, 2026, 09:01 PM UTC L MacroGenics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate Progress Completed MGC028 Phase 1 dose escalation; selected lead indication for dose optimization across two EQUITY | Nov 12, 2026, 09:01 PM UTC L JOURNEY MEDICAL CORPORATION Q3 NET INCOME USD -1.3 MILLION JOURNEY MEDICAL CORPORATION Q3 NET INCOME USD -1.3 MILLION FX | Nov 12, 2026, 09:01 PM UTC L Smith Micro Reports Third Quarter 2026 Financial Results PITTSBURGH--(BUSINESS WIRE)-- Smith Micro Software, Inc. (Nasdaq: SMSI) (“Smith Micro” or the “Compa EQUITY | Nov 12, 2026, 09:01 PM UTC L HEARTFLOW INC Q3 NET INCOME USD -11.505 MILLION HEARTFLOW INC Q3 NET INCOME USD -11.505 MILLION FX | Nov 12, 2026, 09:01 PM UTC L US Government Is $716.8B Below $41.1T Borrowing Limit As Of November 10 — Tsy US Government Is $716.8B Below $41.1T Borrowing Limit As Of November 10 — Tsy NEWS | Nov 12, 2026, 09:01 PM UTC L LIFEWAY FOODS Q3 GROSS PROFIT USD 12.164 MILLION LIFEWAY FOODS Q3 GROSS PROFIT USD 12.164 MILLION EARNINGS | Nov 12, 2026, 09:01 PM UTC L AMAT Reports Q4 Adjusted Operating Margin of 35.3% EARNINGS | Nov 12, 2026, 09:01 PM UTC L XTI Aerospace Restructures About $4.7 Million in Promissory Notes XTI Aerospace says it completed the restructuring of approximately $4.7 million of promissory notes. EQUITY | Nov 12, 2026, 09:01 PM UTC L Smith Micro Software, Inc. (SMSI) Q3 Revenue Rises 16% Sequentially to $5.0M Third-quarter revenue was $5.0M versus $4.3M a year earlier; GAAP net loss was $1.7M versus $5.2M. Gross margin was 81.6% versus 73.9%, and cash and cash equivalents totaled $2.4M at September 30, 2026.Material DetailsCo EARNINGS | Nov 12, 2026, 09:01 PM UTC L Lifeway Foods® Reports Record High Quarterly Net Sales, Extends Kefir Category Leadership in Third Quarter 2026 28th consecutive quarter of year-over-year net sales growth; year-to-date 2026 net sales up 25.8%MORTON GROVE, Ill., Nov. 12, 2026 // -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. s EQUITY | Nov 12, 2026, 09:01 PM UTC H Workhorse Group Postpones 3Q Earnings Release to Nov. 16 From Nov. 12 Workhorse Group Postpones 3Q Earnings Release to Nov. 16 From Nov. 12 EARNINGS | Nov 12, 2026, 09:01 PM UTC L AMAT Reports Q4 Net Income of USD 2,718 Million EARNINGS | Nov 12, 2026, 09:01 PM UTC L Macrogenics 3Q Rev $18.7M >MGNX Macrogenics 3Q Rev $18.7M >MGNX EQUITY | Nov 12, 2026, 09:01 PM UTC L ELECTRA THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT PORTFOLIO HIGHLIGHTS ELECTRA THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT PORTFOLIO HIGHLIGHTS EQUITY | Nov 12, 2026, 09:01 PM UTC L MACROGENICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS RECENT CORPORATE PROGRESS MACROGENICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS RECENT CORPORATE PROGRESS EQUITY | Nov 12, 2026, 09:01 PM UTC L POSABIT SYSTEMS CORPORATION Q3 GROSS MARGIN 87% POSABIT SYSTEMS CORPORATION Q3 GROSS MARGIN 87% EQUITY | Nov 12, 2026, 09:01 PM UTC L SMITH MICRO SOFTWARE Q3 OPERATING INCOME USD -1.462 MILLION SMITH MICRO SOFTWARE Q3 OPERATING INCOME USD -1.462 MILLION FX | Nov 12, 2026, 09:01 PM UTC L ERASCA REPORTS THIRD QUARTER 2026 BUSINESS UPDATES AND FINANCIAL RESULTS ERASCA REPORTS THIRD QUARTER 2026 BUSINESS UPDATES AND FINANCIAL RESULTS EQUITY | Nov 12, 2026, 09:01 PM UTC L Macrogenics 3Q Loss/Shr 32c >MGNX Macrogenics 3Q Loss/Shr 32c >MGNX EQUITY | Nov 12, 2026, 09:01 PM UTC L POSABIT REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS POSABIT REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 09:01 PM UTC L HEARTFLOW INC Q3 GROSS PROFIT USD 60.917 MILLION HEARTFLOW INC Q3 GROSS PROFIT USD 60.917 MILLION EARNINGS | Nov 12, 2026, 09:01 PM UTC L TALPHERA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE TALPHERA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE EQUITY | Nov 12, 2026, 09:01 PM UTC L Applied Materials Reports Fourth-Quarter EPS of $3.40 EARNINGS | Nov 12, 2026, 09:01 PM UTC L Applied Materials reports fourth-quarter net income of $2.72 billion EARNINGS | Nov 12, 2026, 09:01 PM UTC